GleanMark is free for all of AprilGet free access
LARIMAR THERAPEUTICS, INC. logo

LARIMAR THERAPEUTICS, INC.

7 Marks
Corp.
First Filed:May 24, 2019Latest Filed:Sep 10, 2024Address:Three Bala Plaza East, Suite 506, Bala Cynwyd, PA 19004

Portfolio Overview

Registered
2(29%)
Pending
5(71%)

Top Classes

Class 5
Pharmaceuticals
7(100%)
Class 42
Software, IT Services & Scientific Research
1(14%)

TTAB Proceedings

No litigation activity

Top Firms

McCarter & English, LLP(Sep 2024)
7

Trademark Portfolio

7 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
FRAXBALA
FRAXBALA
Trademark
Word
ITU
PENDING
Owner:
Serial:98743148
Filed:Sep 10, 2024
Classes:5
Goods & Services
pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy
FRAXLANZA
FRAXLANZA
Trademark
Word
ITU
PENDING
Owner:
Serial:98743154
Filed:Sep 10, 2024
Classes:5
Goods & Services
pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy
HUFRAXTA
HUFRAXTA
Trademark
Word
ITU
PENDING
Owner:
Serial:98743134
Filed:Sep 10, 2024
Classes:5
Goods & Services
pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy
JEMFRAXTA
JEMFRAXTA
Trademark
Word
ITU
PENDING
Owner:
Serial:98743162
Filed:Sep 10, 2024
Classes:5
Goods & Services
pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy
UFRAXTA
UFRAXTA
Trademark
Word
ITU
PENDING
Owner:
Serial:98743106
Filed:Sep 10, 2024
Classes:5
Goods & Services
pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy
LARIMAR THERAPEUTICS
LARIMAR THERAPEUTICS
Trademark
Combined
REGISTERED
Owner:
Serial:90059153
Filed:Jul 17, 2020
Classes:5, 42
Registration:7340237
Registered:Mar 26, 2024
Goods & Services
Class 005: Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; Class 042: Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
LARIMAR
LARIMAR
Trademark
Word
REGISTERED
Owner:
Serial:88446118
Filed:May 24, 2019
Classes:5
Registration:6980603
Registered:Feb 14, 2023
Goods & Services
Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy | Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases